Evidence map›Paper›PMID 37456051›Full record

ReviewHeliyon2023

Cardiac imaging for the prediction of sudden cardiac arrest in patients with heart failure.

Francesca De Lio, Alessandro Andreis, Giulia De Lio, Matteo Bellettini, Stefano Pidello, Claudia Raineri, Guglielmo Gallone, Gianluca Alunni, Simone Frea, Massimo Imazio and 2 more

Open access · goldAbstract readReview
In one paragraph

Review in Heliyon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Francesca De LioDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Alessandro AndreisDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Giulia De LioDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Matteo BellettiniDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Stefano PidelloDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Claudia RaineriDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Guglielmo GalloneDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Gianluca AlunniDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Simone FreaDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Massimo ImazioCardiology Unit, Cardiothoracic Department, University Hospital "Santa Maria della Misericordia", Udine, Italy.
Davide CastagnoDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
Gaetano Maria De FerrariDivision of Cardiology, Città della Salute e della Scienza di Torino University Hospital, University of Torino, Turin, Italy.
University of Turin · ITOspedale Santa Maria della Misericordia di Udine · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The identification of heart failure (HF) patients at risk for arrhythmic sudden cardiac arrest (SCA) is a major challenge in the cardiovascular field. In addition to optimal medical treatment for HF, implantable cardioverter defibrillator (ICD) is currently recommended to prevent SCA in patients with reduced left ventricular ejection fraction (LVEF). The indication for an ICD implantation, in addition to HF etiology, New York Health Association (NYHA) class and life expectancy, mainly depends on LVEF value at echocardiography. However, the actual role of LVEF in the prediction of SCA has recently been debated, while newer multimodality imaging techniques with increased prognostic accuracy have been developed. Speckle tracking imaging allows the quantification of mechanical dispersion, a marker of electrophysiological heterogeneity predisposing to malignant arrhythmias, while advanced cardiac magnetic resonance techniques such as myocardial T1-mapping and extracellular volume fraction assessment allow the evaluation of interstitial diffuse fibrosis. Nuclear imaging is helpful for the appraisal of sympathetic nervous system dysfunction, while newer computed tomography techniques assessing myocardial delayed enhancement allow the identification of focal myocardial scar. This review will focus on the most modern advances in the field of cardiovascular imaging along with its applications for the prediction of SCA in patients with HF. Modern artificial intelligence applications in cardiovascular imaging will also be discussed.

Indexed as

ArrhythmiasCardiac imagingCardiac magnetic resonanceDiastoleHeart failureICDSpeckle trackingSudden deathVentricular fibrillationVentricular tachycardia

Identifiers

PMID37456051
PMCPMC10338975
OpenAlexW4382467968

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.